Belgium: Thermo Fisher acquires Henogen for €725m

Thermo Fisher Scientific, the world’s largest maker of scientific instruments, is to acquire Belgian viral vector manufacturing business Henogen for €725m (US$880.3m) in cash. A subsidiary of Groupe Novasep, Henogen provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers from two locations in Seneffe and Gosselies. Founded more than…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »